Single-implant Overdentures Retained by the Novaloc Attachment System

September 3, 2021 updated by: McGill University

Single-implant Overdentures Retained by the Novaloc Attachment System: Study Protocol for a Mixed Methods Randomized Cross-over Trial

The objective of this explanatory mixed methods study is to compare a novel attachment system (Novaloc) to a traditional alternative (Locator) for single implants in the mandible of edentate elders. The investigators will carry out a randomized cross-over clinical trial comparing Novaloc attachments to Locators for single-implant mandibular overdentures in edentate elders. Participants will be followed for three months with each attachment type; patient-based, clinical and economic outcomes will be gathered. A sample of 26 participants is estimated to be required to detect clinically relevant differences in terms of the primary outcome (patient ratings of general satisfaction). Participants will choose which attachment they wish to keep, then be interviewed about their experiences and preferences with a single implant prosthesis and with the 2 attachments. Data from the quantitative and qualitative assessments will be integrated through a mixed-methods explanatory strategy. A last quantitative assessment will take place after 12 months with preferred attachment; this latter assessment will enable the observation of attachments' long-term wear and maintenance events.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H3A1G1
        • McGill University, Faculty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

63 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Not have had a tooth extraction within the past six months
  • Request implant stabilization of a mandibular conventional complete denture
  • Have clinically acceptable maxillary and mandibular complete dentures
  • Have adequate bone in the anterior mandible for the placement of a single 3.3 mm wide implant in the midline
  • Be able to maintain adequate oral hygiene and clean dentures;
  • Present no systemic conditions for which minor oral surgery would be counter-indicated
  • Have an adequate understanding of written and spoken English or French;
  • Be capable of giving written informed consent

Exclusion Criteria:

  • Severe/serious illness that requires frequent hospitalization
  • Impaired cognitive function
  • Unable to return for evaluations/study recalls
  • Have a history of radiation therapy to the orofacial region
  • Have specific conditions that may jeopardize the treatment, such as alcoholism or smoking (>10 cigarettes/day)
  • Have acute or chronic symptoms of parafunctional or temporomandibular disorders
  • Previous dental implant treatment

Following radiographic exam, investigators will exclude volunteers with bony pathologic lesions, less than 11 mm of minimum vertical mandibular bone height in the midline or width for planned implants, evident endosseous vascular structures or mandibular ridges with remaining alveolar sockets

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Novaloc, then Locator
Participants will receive the Novaloc attachment on a single implant inserted in the mandibular midline. This attachment will be used for 3 months and then changed by the Locator attachment. The second attachment will be used for another 3-month period. Participants will keep preferred attachment for further 12 months
Attachment composed by a polyetheretherketone (PEEK) capsule and carbon-coated abutment. The yellow (medium) retentive component will be used
Traditional cylindrical attachment (Locator system) with pink (medium) retentive components
Active Comparator: Locator, then Novaloc
Participants will receive the Locator attachment on a single implant inserted in the mandibular midline. This attachment will be used for 3 months and then changed by the Novaloc attachment. The second attachment will be used for another 3-month period. Participants will keep preferred attachment for further 12 months
Attachment composed by a polyetheretherketone (PEEK) capsule and carbon-coated abutment. The yellow (medium) retentive component will be used
Traditional cylindrical attachment (Locator system) with pink (medium) retentive components

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Denture satisfaction
Time Frame: 18 months
To be assessed by specific questionnaires
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral health-related quality of life
Time Frame: 18 months
To be assessed by the OHIP-EDENT (Oral Health Impact Profile, shortened version for edentulous subjects) questionnaire
18 months
Overdenture rotation
Time Frame: 18 months
Two questions regarding perceived rotation, as done by Kimoto et al. (Clin Oral Implants Res 2009;20:838-43)
18 months
Success/survival rate
Time Frame: 18 months
Success/survival rate of prostheses and implants (yes/no)
18 months
Plaque Index
Time Frame: 18 months
Presence of plaque according to Silness & Loe (Acta Odont Scand 1963;21:533-51) (ordinal scale ranging from 0 to 3)
18 months
Presence of calculus
Time Frame: 18 months
Presence of calculus according to Ramfjord (J Periodontol 1967;38:602-10) (ordinal scale ranging from 0 to 3)
18 months
Peri-implant probing depth
Time Frame: 18 months
Depth of peri-implant pockets (in mm)
18 months
Bleeding on probing
Time Frame: 18 months
Bleeding on probing around implant (yes/no)
18 months
Mucosal inflammation
Time Frame: 18 months
Signs of swelling or inflammation of the peri-implant-mucosa (yes/no, plus categorical evaluation - type of pathological change)
18 months
Treatment costs
Time Frame: 18 months
Specific forms quantifying costs involved with cost of labor, materials, radiographs, medications, patient's time and transportation expenses
18 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative assessment
Time Frame: 6 months
Qualitative assessment (descriptive approach based on transcribed interviews) regarding: a) patients' reasons for choosing one attachment system; b) their perceptions of the advantages and disadvantages of each attachment; and c) their experience of living with a single implant retention for their mandibular overdenture
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Raphael F de Souza, McGill University, Faculty of Dentistry

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Actual)

September 30, 2020

Study Completion (Actual)

March 8, 2021

Study Registration Dates

First Submitted

April 13, 2017

First Submitted That Met QC Criteria

April 24, 2017

First Posted (Actual)

April 25, 2017

Study Record Updates

Last Update Posted (Actual)

September 5, 2021

Last Update Submitted That Met QC Criteria

September 3, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Edentulous Jaw

Clinical Trials on Novaloc

3
Subscribe